Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–3 of 3 results
Advanced filters: Author: Ingo H Tarner Clear advanced filters
  • Our improved understanding of the intercellular and intracellular pathways involved in the pathophysiology of rheumatoid arthritis has enabled novel targets for biologic agents to be identified. The most promising of these targets, which include cytokines, adipokines and microparticles, are discussed in this Review.

    • Ingo H Tarner
    • Ulf Müller-Ladner
    • Steffen Gay
    Reviews
    Nature Clinical Practice Rheumatology
    Volume: 3, P: 336-345
  • The creation of specific immune tolerance would allow autoimmune disease to be reversed without the need for nonspecific and potentially harmful immunosuppressive therapy. Important progress in research into immune tolerance is summarized in this Review, and the potential use of this technique in immunotherapy of autoimmune disease is discussed.

    • Ingo H Tarner
    • C Garrison Fathman
    Reviews
    Nature Clinical Practice Rheumatology
    Volume: 2, P: 491-499
  • Rheumatoid arthritis usually begins in one joint but spreads to other joints as the disease progresses. Elena Neumann and her colleagues show that rheumatoid arthritis synovial fibroblasts (RASFs) may be key mediators of this process. They show, using a SCID mouse model, that human RASFs can migrate long distances through the bloodstream from diseased cartilage to unaffected cartilage, where they can mount a new attack.

    • Stephanie Lefèvre
    • Anette Knedla
    • Elena Neumann
    Research
    Nature Medicine
    Volume: 15, P: 1414-1420